Skip to content
Open access · CC-BY via OpenAlex

Rapamycin extends life- and health span because it slows aging

Mikhail V. Blagosklonny

Aging · 2013 · ▲ 83 citations

Abstract

Making headlines, a thought-provocative paper by Neff, Ehninger and coworkers claims that mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) extends life span but has limited effects on aging. How is that possibly possible? And what is aging if not an increase of the probability of death with age. I discuss that the JCI paper actually shows that rapamycin slows aging and also extends lifespan regardless of its direct anti-cancer activities. Aging is, in part, MTOR-driven: a purposeless continuation of developmental growth. Rapamycin affects the same processes in young and old animals: young animals' traits and phenotypes, which continuations become hyperfunctional, harmful and lethal later in life.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.18632/aging.100591
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Blagosklonny, M.V. (2013). Rapamycin extends life- and health span because it slows aging. <em>Aging</em>. https://doi.org/10.18632/aging.100591
Vancouver
Blagosklonny MV. Rapamycin extends life- and health span because it slows aging. Aging. 2013. doi:10.18632/aging.100591.
BibTeX
@article{mikhail2013Rapamy, title = {Rapamycin extends life- and health span because it slows aging}, author = {Mikhail V. Blagosklonny}, journal = {Aging}, year = {2013}, doi = {10.18632/aging.100591}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings

Elsevier eBooks 2022
Citation only

Aging

▲ 1